Keyphrases
Non-valvular Atrial Fibrillation
100%
Left Atrial Appendage
100%
Stroke Prevention
100%
Oral Anticoagulation
100%
Atrial Fibrillation
50%
Cardioembolism
50%
Alternative Therapy
33%
Watchman
33%
Heart Failure
16%
Non-pharmacological
16%
Fatal Complication
16%
Clinical Practice
16%
Randomized Controlled Trial
16%
Non-inferiority
16%
Palpation
16%
Watchman FLX
16%
Percutaneous Left Atrial Appendage Closure
16%
Coagulation
16%
Stroke Risk
16%
Antithrombotic Therapy
16%
Arrhythmia
16%
High Bleeding Risk
16%
Oral Anticoagulant Therapy
16%
Non-pharmacological Therapy
16%
High Failure Rate
16%
Embolic Event
16%
Device-related Thrombus
16%
Vitamin K Antagonists
16%
Boston Scientific
16%
High Bleeding Risk Patients
16%
Safety Events
16%
Marlborough
16%
Direct Oral
16%
Appendage Closure
16%
Peri-device Leakage
16%
HAS-BLED Score
16%
Medicine and Dentistry
Apoplexy
100%
Atrial Fibrillation
100%
Anticoagulation
100%
Drug Therapy
16%
Contraindication
16%
Thrombosis
16%
Bleeding
16%
Prevalence
16%
Randomized Controlled Trial
16%
Congestive Heart Failure
16%
Anticoagulant Therapy
16%
Palpitations
16%
Cardiac Dysrhythmia
16%
Antithrombotic Therapy
16%
Vitamin K Antagonist
16%